ofloxacin has been researched along with Fever in 48 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 g piperacillin/tazobactam 3 times a day in patients with low-risk febrile neutropenia." | 9.11 | Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia. ( Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T, 2004) |
| "Outpatient oral antibiotic therapy with oral ofloxacin for patients with low risk neutropenia and fever is safe and similar in efficacy to hospitalization and treatment with broad-spectrum parenteral antibiotics." | 9.09 | Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial. ( Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM, 1999) |
| "The appropriate administration method of levofloxacin in relation to symptoms was investigated by following up 2,353 patients prescribed either levofloxacin (300 mg divided into 3 doses) or 400 mg (divided into 2 doses) for the treatment of acute upper respiratory tract infection accompanied by fever (temperature (> or = 38 degrees C) of suspected bacterial infection." | 7.72 | [Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)]. ( Matsumoto, T; Odagiri, S; Uchino, K; Yamaguchi, H; Yokoyama, H, 2003) |
| " is predicted to be the most effective dosage and method." | 6.73 | Population pharmacokinetics of levofloxacin as prophylaxis for febrile neutropenia. ( Fujimoto, Y; Kanbayashi, Y; Matsumoto, Y; Morimoto, Y; Nomura, K; Taniwaki, M, 2008) |
| "Bacteremia was documented in two patients in the O+R group and six in the control group (p=0." | 5.30 | Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. ( Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A, 1999) |
| "An open-label randomised clinical trial was designed to compare the efficacy and tolerance of levofloxacin and ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with high-risk neutropenia, and to monitor the emergence of antimicrobial resistance." | 5.12 | Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies. ( Huijgens, PC; Janssen, JJ; Leidekker, ME; Simoons-Smit, AM; Timmers, GJ; Vandenbroucke-Grauls, CM, 2007) |
| "5 g piperacillin/tazobactam 3 times a day in patients with low-risk febrile neutropenia." | 5.11 | Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia. ( Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T, 2004) |
| "Among patients receiving chemotherapy for solid tumors or lymphoma, the prophylactic use of levofloxacin reduces the incidence of fever, probable infection, and hospitalization." | 5.11 | Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. ( Billingham, L; Bower, M; Cullen, M; Fernando, I; Gaunt, C; Gollins, S; Hastings, M; Huddart, R; Rea, D; Simmonds, P; Stanley, A; Steven, N; Stuart, N, 2005) |
| "Outpatient oral antibiotic therapy with oral ofloxacin for patients with low risk neutropenia and fever is safe and similar in efficacy to hospitalization and treatment with broad-spectrum parenteral antibiotics." | 5.09 | Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial. ( Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM, 1999) |
| " After an initial work-up for fever, patients were randomized to receive oral ofloxacin 400 mg immediately and twice daily thereafter in the hospital or as outpatients." | 5.08 | Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial. ( Aziz, Z; Karim, M; Khan, MA; Khan, WA; Malik, IA, 1995) |
| " We conducted a prospective non-randomised trial to evaluate the efficacy of administration of oral ofloxacin by caregivers to paediatric cancer patients with fever and neutropenia." | 5.08 | Out-patient management of febrile neutropenia in indigent paediatric patients. ( Malik, IA, 1997) |
| " In a prospective, randomized, open trial, we evaluated the efficacy and safety of oral roxithromycin (150 mg twice daily) as additional antibacterial prophylaxis in 131 adult patients with acute leukemia and bone marrow transplant recipients receiving oral ofloxacin." | 5.07 | A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. ( Arnold, R; Hay, B; Kern, P; Kern, WV; Marre, R, 1994) |
| "The appropriate administration method of levofloxacin in relation to symptoms was investigated by following up 2,353 patients prescribed either levofloxacin (300 mg divided into 3 doses) or 400 mg (divided into 2 doses) for the treatment of acute upper respiratory tract infection accompanied by fever (temperature (> or = 38 degrees C) of suspected bacterial infection." | 3.72 | [Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)]. ( Matsumoto, T; Odagiri, S; Uchino, K; Yamaguchi, H; Yokoyama, H, 2003) |
| "Vancomycin has been used with increased frequency during the past 15 years and the most common toxicity with this drug is the red man syndrome ." | 3.71 | Uncommon vancomycin-induced side effects. ( Baptista, MI; Da Cunha, CA; Kondo, W; Martins, LT; Rocha, JL, 2002) |
| "We report a case of bacteremia due to Abiotrophia species in a patient with neutropenic fever and cancer who was receiving levofloxacin prophylaxis, followed by empirical therapy with cefepime; the organism was resistant to both antibiotics." | 3.71 | Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates. ( Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA, 2001) |
| "When seven elderly patients with fever due to bacterial infection failed to respond to ofloxacin 300 mg/day for 3 days, we prescribed Mao-bushi-saishin-to for 7 days." | 3.70 | Effect of Mao-bushi-saishin-to on infection of ofloxacin resistant bacteria and of unknown origin. ( Kamei, T; Tomioka, H; Toriumi, Y, 2000) |
| "We evaluated the efficacy and toxicity of piperacillin-ofloxacin as an empiric treatment of fever in patients with neutropenia." | 3.68 | [Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study]. ( Brisseau, JM; Feve, B; Grolleau, JY; Raffi, F; Reynaud, AE; Tiab, M, 1990) |
| "A treatment with ofloxacin for 7 days was inferior to 14 days for febrile UTI in men and should therefore not be recommended." | 3.30 | Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial. ( Abgrall, S; Aparicio, C; Aumaitre, H; Bercot, B; Bernard, L; Bourgarit-Durand, A; Bruyere, F; Canoui, E; Chabrol, A; Charlier, C; Chevret, S; de Lastours, V; Desseaux, K; Empana-Barat, F; Escaut, L; Etienne, M; Ferreyra, M; Fontaine, JP; Garrait, V; Gatey, C; Grall, N; Jaureguiberry, S; Lafaurie, M; Lefort, A; Madeleine, I; Meyssonnier, V; Molina, JM; Mongiat-Artus, P; Morrier, M; Pacanowski, J; Piet, E; Talarmin, JP, 2023) |
| "The series is part of an ongoing randomised controlled trial assessing rechallenge dosing following TB-associated cutaneous ADR." | 2.77 | Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients. ( Dheda, K; Lehloenya, RJ; Todd, G; Wallace, J, 2012) |
| " is predicted to be the most effective dosage and method." | 2.73 | Population pharmacokinetics of levofloxacin as prophylaxis for febrile neutropenia. ( Fujimoto, Y; Kanbayashi, Y; Matsumoto, Y; Morimoto, Y; Nomura, K; Taniwaki, M, 2008) |
| "Ciprofloxacin was therefore superior to the other two fluoroquinolones in preventing infections due to Gram-negative bacteria in this population of neutropenic patients." | 2.67 | Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. ( Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM, 1994) |
| "Oral ofloxacin was associated with a relatively low incidence of documented bacterial infection and related mortality, although it did not obviate the need for frequent empiric antimicrobial therapy due to a high incidence of febrile episodes." | 2.67 | Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients. ( Arnold, R; Hay, B; Hertenstein, B; Kern, WV; Schmeiser, T, 1993) |
| " In practice, adverse events (AEs) of BCG therapy could restrict its prescription by urologists." | 2.48 | [Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology]. ( Davin, JL; Irani, J; Larré, S; Moreau, JL; Neuzillet, Y; Pfister, C; Pignot, G; Rouprêt, M; Soulié, M; Wallerand, H, 2012) |
| "Thus, up to date management of cancer patients, in addition to other supportive care modalities, should also incorporate diagnostic methods and therapy of infections." | 2.47 | [Treatment and prevention of infections in cancer patients with neutropenia]. ( Sinkó, J, 2011) |
| "We found serological evidence of acute murine typhus in 21 of 125 (17%) patients, with 12 of 21 (57%) patients polymerase chain reaction (PCR)-positive for Rickettsia typhi." | 1.42 | Undifferentiated febrile illness in Kathmandu, Nepal. ( Arjyal, A; Baker, S; Basnyat, B; Blacksell, SD; Day, N; Dolecek, C; Dongol, S; Farrar, J; Giri, A; Karkey, A; Paris, DH; Thompson, CN; Thwaites, G, 2015) |
| " No significant difference in various pharmacokinetic parameters of plasma was observed in healthy calves ( β=0." | 1.35 | Pharmacokinetic studies of levofloxacin after oral administration in healthy and febrile cow calves. ( Kumar, S; Kumar, V; Roy, BK; Singh, KK, 2009) |
| "Although it is rare, acute pancreatitis must be considered when evaluating patients presenting with abdominal pain and/or ascites in the postpartum period." | 1.33 | Ascites in the puerperium: a missed diagnosis of acute postpartum pancreatitis. ( Fakokunde, A; Gyang, A; Kalu, E; Whitlow, B, 2005) |
| "Bacteremia was documented in two patients in the O+R group and six in the control group (p=0." | 1.30 | Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. ( Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (20.83) | 18.2507 |
| 2000's | 25 (52.08) | 29.6817 |
| 2010's | 11 (22.92) | 24.3611 |
| 2020's | 2 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Lafaurie, M | 1 |
| Chevret, S | 1 |
| Fontaine, JP | 1 |
| Mongiat-Artus, P | 1 |
| de Lastours, V | 1 |
| Escaut, L | 1 |
| Jaureguiberry, S | 1 |
| Bernard, L | 1 |
| Bruyere, F | 1 |
| Gatey, C | 1 |
| Abgrall, S | 1 |
| Ferreyra, M | 1 |
| Aumaitre, H | 1 |
| Aparicio, C | 1 |
| Garrait, V | 1 |
| Meyssonnier, V | 1 |
| Bourgarit-Durand, A | 1 |
| Chabrol, A | 1 |
| Piet, E | 1 |
| Talarmin, JP | 1 |
| Morrier, M | 1 |
| Canoui, E | 1 |
| Charlier, C | 1 |
| Etienne, M | 1 |
| Pacanowski, J | 1 |
| Grall, N | 1 |
| Desseaux, K | 1 |
| Empana-Barat, F | 1 |
| Madeleine, I | 1 |
| Bercot, B | 1 |
| Molina, JM | 1 |
| Lefort, A | 1 |
| Pokharel, S | 1 |
| Karki, M | 1 |
| Acharya, B | 1 |
| Marasini, B | 1 |
| Arjyal, A | 2 |
| Assez, N | 1 |
| Mauriaucourt, P | 1 |
| Cuny, J | 1 |
| Goldstein, P | 1 |
| Wiel, E | 1 |
| Thompson, CN | 1 |
| Blacksell, SD | 1 |
| Paris, DH | 1 |
| Karkey, A | 1 |
| Dongol, S | 1 |
| Giri, A | 1 |
| Dolecek, C | 1 |
| Day, N | 1 |
| Baker, S | 1 |
| Thwaites, G | 1 |
| Farrar, J | 1 |
| Basnyat, B | 1 |
| Sokolova, GB | 1 |
| Kirtaeva, OV | 1 |
| Lazareva, IaV | 1 |
| Tsybanev, AA | 1 |
| Kumar, S | 2 |
| Kumar, V | 1 |
| Singh, KK | 1 |
| Roy, BK | 1 |
| Gupta, A | 1 |
| Swaroop, C | 1 |
| Agarwala, S | 1 |
| Pandey, RM | 1 |
| Bakhshi, S | 1 |
| Bellesso, M | 1 |
| Costa, SF | 1 |
| Pracchia, LF | 1 |
| Santos Dias, LC | 1 |
| Chamone, D | 1 |
| Dorlhiac-Llacer, PE | 1 |
| Yotsu, R | 1 |
| Mii, S | 1 |
| Hayashi, R | 1 |
| Harada, H | 1 |
| Furukawa, K | 1 |
| Eto, H | 1 |
| Kondo, M | 1 |
| Kurokawa, I | 1 |
| Yamanaka, K | 1 |
| Akachi, S | 1 |
| Nishii, M | 1 |
| Sinkó, J | 1 |
| Manecksha, RP | 1 |
| Nason, GJ | 1 |
| Cullen, IM | 1 |
| Fennell, JP | 1 |
| McEvoy, E | 1 |
| McDermott, T | 1 |
| Flynn, RJ | 1 |
| Grainger, R | 1 |
| Thornhill, JA | 1 |
| Cascio, A | 1 |
| Stassi, G | 1 |
| Cacciola, I | 1 |
| Saitta, C | 1 |
| Squadrito, G | 1 |
| Lehloenya, RJ | 1 |
| Wallace, J | 1 |
| Todd, G | 1 |
| Dheda, K | 1 |
| Neuzillet, Y | 1 |
| Rouprêt, M | 1 |
| Wallerand, H | 1 |
| Pignot, G | 1 |
| Larré, S | 1 |
| Irani, J | 1 |
| Davin, JL | 1 |
| Moreau, JL | 1 |
| Soulié, M | 1 |
| Pfister, C | 1 |
| Ertas, F | 1 |
| Acet, H | 1 |
| Kaya, H | 1 |
| Kayan, F | 1 |
| Soydinc, S | 1 |
| Rocha, JL | 1 |
| Kondo, W | 1 |
| Baptista, MI | 1 |
| Da Cunha, CA | 1 |
| Martins, LT | 1 |
| Gonzales, R | 1 |
| Smith, MD | 1 |
| Gradon, JD | 1 |
| Cornely, OA | 1 |
| Wicke, T | 1 |
| Seifert, H | 1 |
| Bethe, U | 1 |
| Schwonzen, M | 1 |
| Reichert, D | 1 |
| Ullmann, AJ | 1 |
| Karthaus, M | 1 |
| Breuer, K | 1 |
| Salzberger, B | 1 |
| Diehl, V | 1 |
| Fätkenheuer, G | 1 |
| Yamaguchi, H | 1 |
| Uchino, K | 1 |
| Yokoyama, H | 1 |
| Matsumoto, T | 1 |
| Odagiri, S | 1 |
| Medford, AR | 1 |
| Rabar, D | 1 |
| Issartel, B | 1 |
| Petiot, P | 1 |
| Boibieux, A | 1 |
| Chidiac, C | 1 |
| Peyramond, D | 1 |
| Gyang, A | 1 |
| Kalu, E | 1 |
| Fakokunde, A | 1 |
| Whitlow, B | 1 |
| Cullen, M | 1 |
| Steven, N | 1 |
| Billingham, L | 1 |
| Gaunt, C | 1 |
| Hastings, M | 1 |
| Simmonds, P | 1 |
| Stuart, N | 1 |
| Rea, D | 1 |
| Bower, M | 1 |
| Fernando, I | 1 |
| Huddart, R | 1 |
| Gollins, S | 1 |
| Stanley, A | 1 |
| Baden, LR | 1 |
| Pasqualotto, AC | 1 |
| Rosa, DD | 1 |
| Machado, AL | 1 |
| Almyroudis, NG | 1 |
| Segal, BH | 1 |
| Castagna, L | 1 |
| Santoro, A | 1 |
| Timmers, GJ | 1 |
| Simoons-Smit, AM | 1 |
| Leidekker, ME | 1 |
| Janssen, JJ | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Huijgens, PC | 1 |
| Yamamoto, A | 1 |
| Konishi, I | 1 |
| Kumata, M | 1 |
| Foo, SS | 1 |
| Lye, DC | 1 |
| Listernick, R | 1 |
| Nomura, K | 1 |
| Fujimoto, Y | 1 |
| Morimoto, Y | 1 |
| Kanbayashi, Y | 1 |
| Matsumoto, Y | 1 |
| Taniwaki, M | 1 |
| Malik, IA | 3 |
| Khan, WA | 1 |
| Karim, M | 2 |
| Aziz, Z | 1 |
| Khan, MA | 1 |
| D'Antonio, D | 1 |
| Piccolomini, R | 1 |
| Iacone, A | 1 |
| Fioritoni, G | 1 |
| Parruti, G | 1 |
| Betti, S | 1 |
| Quaglietta, AM | 1 |
| Accorsi, P | 1 |
| Dell'Isola, M | 1 |
| Favalli, C | 1 |
| Kern, WV | 2 |
| Hay, B | 2 |
| Kern, P | 1 |
| Marre, R | 1 |
| Arnold, R | 2 |
| Schmeiser, T | 1 |
| Hertenstein, B | 1 |
| Hidalgo, M | 1 |
| Hornedo, J | 1 |
| Lumbreras, C | 1 |
| Trigo, JM | 1 |
| Colomer, R | 1 |
| Perea, S | 1 |
| Gómez, C | 1 |
| Ruiz, A | 1 |
| García-Carbonero, R | 1 |
| Cortés-Funes, H | 1 |
| Papadimitris, C | 1 |
| Dimopoulos, MA | 1 |
| Kostis, E | 1 |
| Papadimitriou, C | 1 |
| Anagnostopoulos, A | 1 |
| Alexopoulos, G | 1 |
| Papamichael, C | 1 |
| Gika, D | 1 |
| Mitsibounas, D | 1 |
| Stamatelopoulos, S | 1 |
| Muñoz, L | 1 |
| Martino, R | 1 |
| Subirà, M | 1 |
| Brunet, S | 1 |
| Sureda, A | 1 |
| Sierra, J | 1 |
| Kamei, T | 1 |
| Toriumi, Y | 1 |
| Tomioka, H | 1 |
| Murray, CK | 1 |
| Walter, EA | 1 |
| Crawford, S | 1 |
| McElmeel, ML | 1 |
| Jorgensen, JH | 1 |
| Flannery, MT | 1 |
| Le, M | 1 |
| Altus, P | 1 |
| Palau, J | 1 |
| Picón, I | 1 |
| Angel Climent, M | 1 |
| Martí, R | 1 |
| Aznar, E | 1 |
| Carmen Sanjuán, M | 1 |
| Máiquez, J | 1 |
| Abbas, Z | 1 |
| Raffi, F | 1 |
| Feve, B | 1 |
| Tiab, M | 1 |
| Brisseau, JM | 1 |
| Reynaud, AE | 1 |
| Grolleau, JY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Parallel Group, Double Blinded, 1:1, Randomized Controlled Phase III Trial of Co-trimoxazole Versus Azithromycin for the Treatment of Undifferentiated Fever In Nepal[NCT02773407] | Phase 3 | 330 participants (Actual) | Interventional | 2016-05-23 | Completed | ||
| A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors[NCT00005590] | Phase 3 | 0 participants | Interventional | 1999-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for ofloxacin and Fever
| Article | Year |
|---|---|
[Fever and jaundice... and if it was a leptospirosis. About a case of L. interrogans icterohaemorrhagiae in Northern France].
Topics: Acute Kidney Injury; Adult; Amoxicillin-Potassium Clavulanate Combination; Animal Husbandry; Animals | 2013 |
[Treatment and prevention of infections in cancer patients with neutropenia].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Bacterial In | 2011 |
[Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anti-Infective Agents, Urinary; Arthralgia; BC | 2012 |
Bacteremia due to Comamonas species possibly associated with exposure to tropical fish.
Topics: Administration, Oral; Aged; Aged, 80 and over; Animals; Animals, Domestic; Anti-Infective Agents; Ba | 2003 |
16 trials available for ofloxacin and Fever
| Article | Year |
|---|---|
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Double-Blind Method; Fever; Humans; Male; Ofloxacin; U | 2023 |
[Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis].
Topics: Adult; Antitubercular Agents; Arthralgia; Diarrhea; Drug Resistance, Multiple, Bacterial; Drug Thera | 2008 |
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combi | 2009 |
Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.
Topics: Adult; Antitubercular Agents; Coinfection; Drug Eruptions; Drug Hypersensitivity; Edema; Eosinophili | 2012 |
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibili | 2004 |
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineopl | 2005 |
Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infecti | 2007 |
Population pharmacokinetics of levofloxacin as prophylaxis for febrile neutropenia.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Dose-Response Relationship, Drug; Female | 2008 |
Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial.
Topics: Adult; Aged; Ambulatory Care; Feasibility Studies; Female; Fever; Fever of Unknown Origin; Humans; M | 1995 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin | 1994 |
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bone Marrow Transplantation; Cyclospo | 1994 |
Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients.
Topics: Administration, Oral; Adolescent; Adult; Bacterial Infections; Bone Marrow Transplantation; Drug Tol | 1993 |
Out-patient management of febrile neutropenia in indigent paediatric patients.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Anti-Infective Agents; Child; Child, Preschool; F | 1997 |
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective | 1999 |
Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amoxicillin; Anti-Infective Agents; Antineoplast | 1999 |
Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cloxacillin; Drug Thera | 1992 |
28 other studies available for ofloxacin and Fever
| Article | Year |
|---|---|
Outbreak of acute undifferentiated febrile illness in Kathmandu, Nepal: clinical and epidemiological investigation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Child; Di | 2020 |
Undifferentiated febrile illness in Kathmandu, Nepal.
Topics: Anti-Bacterial Agents; Fever; Fluoroquinolones; Gatifloxacin; Humans; Nepal; Ofloxacin; Prospective | 2015 |
Pharmacokinetic studies of levofloxacin after oral administration in healthy and febrile cow calves.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Female; Fever; Levofl | 2009 |
Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Fever; Hematologic Neoplasms; Home Infusion | 2011 |
Erythema nodosum associated with Yersinia enterocolitica infection.
Topics: Aged; Diarrhea; Erythema Nodosum; Feces; Female; Fever; Humans; Lymphocytes; Neutrophils; Ofloxacin; | 2010 |
Topical treatment with incision and antiseptic may prevent the severity of Japan spotted fever.
Topics: Aged; Anti-Infective Agents, Local; Ceftriaxone; Erythema; Female; Fever; Humans; Minocycline; Oflox | 2010 |
Prospective study of antibiotic prophylaxis for prostate biopsy involving >1100 men.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Cephalosporins; Drug Resistance, Bacter | 2012 |
Fever and rhomboid target lesion in decompensated cirrhosis.
Topics: Anti-Bacterial Agents; Erysipelothrix; Erysipelothrix Infections; Exanthema; Female; Fever; Humans; | 2012 |
Implantable cardioverter defibrillator pocket infection caused by Klebsiella pneumonia.
Topics: Anti-Bacterial Agents; Defibrillators, Implantable; Echocardiography, Transesophageal; Electrocardio | 2012 |
Uncommon vancomycin-induced side effects.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Eosinophilia; Erythema; Female; Fever; Hip Pros | 2002 |
A 65-year-old woman with acute cough illness and an important engagement.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antitussive Agents; Antiviral Age | 2003 |
[Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Body Temperature; Drug Administration | 2003 |
Case 29-2004: a woman with acute onset of chest pain and fever.
Topics: Aged; Anti-Bacterial Agents; Blood; Chest Pain; Diagnosis, Differential; Endocarditis, Bacterial; Fe | 2005 |
[Tuberculoma and tuberculous meningeal-radiculitis with paradoxical progression during treatment].
Topics: Aged; Anti-Inflammatory Agents; Antitubercular Agents; Confusion; Disease Progression; Drug Therapy, | 2005 |
Ascites in the puerperium: a missed diagnosis of acute postpartum pancreatitis.
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Infective Agents; Ascites; Clarithromycin; Diagnosis, Dif | 2005 |
Prophylactic antimicrobial agents and the importance of fitness.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Drug Res | 2005 |
Antibacterial prophylaxis in patients with cancer and neutropenia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Bacterial Infections; Drug Resistance, Mult | 2006 |
Antibacterial prophylaxis in patients with cancer and neutropenia.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Drug Resistance, Bacteri | 2006 |
Antibacterial prophylaxis in patients with cancer and neutropenia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Fever; Hospitalization; Humans; | 2006 |
[Drug-resistant bacteria isolated from pharyngeal swab cultures and urine in acutely or chronically febrile elderly nursing home inmates].
Topics: Acute Disease; Aged; Chronic Disease; Drug Resistance, Bacterial; Escherichia coli; Fever; Fluoroqui | 2007 |
Methicillin-sensitive Staphylococcus aureus tricuspid valve endocarditis with annular abscess cured with oral levofloxacin and rifampicin.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cloxacillin; Endocarditis, Bacterial; Fever; Humans; Levoflox | 2007 |
A 5-year-old girl with headache and eye pain.
Topics: Abducens Nerve Diseases; Anti-Bacterial Agents; Child, Preschool; Cranial Sinuses; Diagnosis, Differ | 2008 |
Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bact | 1999 |
Effect of Mao-bushi-saishin-to on infection of ofloxacin resistant bacteria and of unknown origin.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Bacterial Infections; Body | 2000 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram | 2001 |
Endocarditis due to Salmonella.
Topics: Aged; Anti-Infective Agents; Cardiac Catheterization; Ceftriaxone; Cephalosporins; Combined Modality | 2001 |
[Infection in patients with neutropenia that undergo an autologous peripheral blood stem cell transplant due to breast cancer].
Topics: Acyclovir; Adult; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Pro | 2001 |
[Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study].
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Drug Therapy, Combination; Fe | 1990 |